Healthcare

Giving Cannabidiol to animals is no longer a weird thing to do. It might have been a bit unusual and strange in the beginning, especially since people didn’t have enough knowledge on the topic. Yet, it soon became a completely normal thing and we have researchers to thank for that, as they have worked hard

Key Highlights: Impossible Foods’ next meatless product is due to reach shelves with its Plant-based pork that claims to be better than the real thing. Impossible Foods discovered that the majority (54 percent) of Hong Kong consumers favored the meatless pork product in a recent blind taste test. Impossible Foods’ meatless pork will be accessible

Key Highlights: SGG and Swiss Re have agreed to work on Carbon Removals projects in Australia utilizing Direct Air Capture of CO2 (DAC). SGG has established a medium-term cost objective of $100 per tonne of CO2. Swiss Re supports for first reducing emissions, then removing them. Collaboration for Carbon Removal SGG and Swiss Re, one

Key Highlights: Premas Biotech has inked a licensing agreement with Oravax Medical Inc. to develop and commercialize its vaccine technology in India. The VLP vaccination technique developed by Premas Biotech is highly scalable, has a low cost of goods, and is easily transferrable. The oral VLP COVID-19 vaccine is being developed to be used as

Key Highlight: The existing initiative provides for the harmonization of data via various data configurations. Healthcare Data Engine will allow organizations to unlock operating costs, drive innovation and achieve better patient involvement. Over 90% of all major electronic record systems can be mapped from the box using HL7v2 communications like medical orders or FHIR patient

Key Highlights: – Researchers look forward to exploring larger groups of patients and using the brace to follow patients through physical therapy to establish evidence-based rehabilitation techniques. – The new brace is the technology that enhances 3D printing materials and cost effective sensors. – The study used the prototype brace to check for five patients

Key Highlights: • Foxconn and TSMC agree on the purchase of 10 million vaccines amid vaccine shortage in Taiwan. • Taiwan’s Cabinet announced that the vaccinations will be given to the government for free. • The first BioNTech vaccines would not arrive until late September. Solving Vaccine Shortage in Taiwan Foxconn and TSMC have agreed

Key Highlights: India has vaccinated about over 8 million people in a single day After suffering from the fatal second wave, the country is gearing up its medical facilities for the upcoming third wave The current vaccine rate is bothersome, as per exerts, provided the lethal impacts of the second wave of the pandemic 8

Key Highlights: An oral solution has been developed by IIT Hyderabad researchers to treat Mucormycosis or the Black Fungus after two years of vigorous examinations The AmB tablets are pocket friendly and patient-friendly due to its slow release into the system The solution has received a waiver for transfers to pharma companies for mass production

Key Highlights: The South Korean government announced that people vaccinated with at least one shot do not require masks outdoors The announcement was an attempt to encourage older residents for vaccination South Korea aims to immunize at least 70% of its entire population by September 7.7% vaccinated so far As the world was on the

Key Highlights: The breath-analyzer test has been developed by a Singapore based startup company Breathonix Breathonix is currently working with the Health Ministry to further detest the effectiveness of the test The Breathonix’s BreFence Go COVID Test System will assess compounds present in human’s exhaled breath to identify strains of COVID-19 virus Several tests and

Key Highlight COVID-19 has been discovered in patients who are recovering or have recovered from the disease. Black Fungus has a 50% of mortality rate. According to experts, there is no risk of a large-scale outbreak of Black fungus in Russia. Black fungus: Life taking diseases Black fungus is scientifically known as Mucormycosis. It (also

Key Highlights The oxygen demand has increased by 600-800% after the second wave of COVID-19. The supply chain is one of the biggest problems in transporting oxygen to the last mile. Ola Foundation partnered with donation platform GiveIndia to provide customers oxygen. Second-wave of pandemic surge the demand for oxygen The recent increase in COVID-19

Key Highlight A listed company can expand and acquire through cash and equity combination. Grab and Altimeter Group goes under SPAC merger. Increasing scope for the fintech, health tech, and Edtech sectors in the South Asian market. Southeast Asian tech giants can acquire the start-ups Southeast Asia’s tech giants could buy up start-ups with funds

Comparison between first and second wave The COVID-19 second wave is spreading rapidly in India and cases are continuously rising. India reported 68,020 new infections, it was counted as the highest number of cases since last year October 2020. Currently, the number of COVID cases in the country has reached 12-million. These cases are mostly

As the next phase of the COVID-19 vaccination drive is about to start in India, from the 1st of April. The food and product delivery giant of India, Swiggy has announced that they are offering to cover the vaccination expenses of more than 2 lakh delivery partners. Swiggy is now a major player in the

In the last few months, the world has seen various big players who are in the competition to provide vaccination. This global vaccination drive is probably one of the biggest drives in history. Here are the major players who are currently providing vaccination: Pfizer/BioNTecn, Moderna, AstraZeneca Vaccine, Gamaleya Research Institute, Janssen, Sinovac, and Bharat Biotech.

Australia’s Therapeutic Goods Administration (TGA) has granted provisional approval to Oxford’s AstraZeneca COVID vaccine on the 16th of February for use in Australia. This will be the second COVID-19 vaccine to receive regulatory approval in Australia after Pfizer-BioNTech. This means that the provisionally approved AstraZeneca COVID vaccine is included in the Australian Register of Therapeutic

India known as the ‘pharmacy of the world’ is supplying its locally produced COVID-19 vaccine to several low and middle-income countries.  According to the Indian Pharmaceutical Alliance, the country’s firms are producing vaccines. These vaccines will be exported mainly to developing countries.  The AstraZeneca vaccine, made by the Serum Institute of India brands the shot

India is now emerging as the World’s leading drugmakers. India will start COVID vaccine exports from today (20th January), this will defiantly be good news for many countries that are not much strong economically. India’s drug regulatory authority, The Central Drugs Standards Control Organization (CDSCO) has approved two coronavirus vaccines:-  Covishield, developed by AstraZeneca & Oxford

India has been fighting the deadly coronavirus pandemic for quite some time now. India has not only launched the world’s biggest vaccination campaign but has also initiated the production of affordable and easy-to-handle vaccines. Moreover, the demand has been pouring from Latin America, Africa, Asia, and some east European countries. India is known as the

The World Health Organization leads an international team of scientists who arrived in China’s central city of Wuhan for COVID-19 origins investigation. They are expected to investigate the origins of the novel coronavirus that sparked the pandemic.  The team arrived late in the morning from Singapore and was likely to head into two weeks of

Pfizer BioNTech have assured us that their COVID-19 vaccine is effective against all the new mutants of the coronavirus. These new variations of the coronavirus have been known to be highly transmissible as it has been discovered all over South Africa and the UK. The scientists from the University of Texas Medical Branch along with students

India will begin the exporting of the locally made COVID-19 vaccine after the immediate launch of the vaccines. If there is a shortage of vaccines to meet local demand, the country will ban exporting the same.  India is about to make 60% of the vaccine produces and many countries are eagerly waiting for the vaccine

Up to 20 people who had recently returned from the UK have been detected to be carrying the mutant strain of the new COVID-19 variant (SARS-CoV-2). The new covid-19 variant has caused a surge of panic across countries with its 70% higher transmission rate. Countries have closed their borders in anticipation of the mutated COVID-19

Crawling its way northward from the southern states of the US, there has been a discovery about a deadly brain-eating amoeba — Naegleria fowleri.  According to the report given by the Centers for Disease Control and Prevention (CDC), it has been noticed that the cases have been advancing northward. As the geographic range has been

The U.S has crossed the 15 million mark of coronavirus cases. As the coronavirus vaccines are nearing, the cases have also been on the rise. Since, Britain has started inoculating people, which has offered hope to the world that the pandemic might end soon. According to state and county data, the record cases in at

Pfizer’s COVID-19 vaccine: Pfizer’s COVID-19 vaccine Applied for the emergency use authorization of its coronavirus vaccine in India. It is the first company to do so as India is the second-highest number of infections in the world. The recently approved Britain vaccine approached Indian authorities on Saturday. VK Paul said on Saturday, “We welcome interest from

A United Nations commission has voted for the removal of Marijuana from the list that categorized it to be a part of the most dangerous drug list. This move has put into importance the medicinal value of the plant. The World Health Organization on Wednesday recommended the removal of cannabis and cannabis resin from its

Moderna, a US-based pharmaceutical company has applied to the FDA authorization of its covid-19 vaccine. The company has asked the US FDA for authorization to administer the drug to patients after a review of its expanded data.  According to recent news reports, the company’s vaccine is 94.1% effective at immunization. Moreover, the company also claims

CoronaVac, the experimental COVID-19 vaccine made by Sinovac Biotech, triggered a quick immune response, however; the levels of the antibodies produced were drastically reduced in people who had recovered from the disease.  Researches have put forth that the CoronaVac could provide sufficient protection, based on their experience with other vaccines and data from preclinical studies

US-based pharma company Pfizer Inc and German Biotech company BioNTech announced that their mRNA-based COVID vaccine candidate, BNT162b2, has demonstrated evidence of efficacy against COVID-19 in patients. The first interim efficacy analysis conducted on November 8, 2020, by an external, independent Data Monitoring Committee (DMC), stated this from the Phase 3 clinical trial. Pfizer said

The only manufacturer that combines a wearable, app, and algorithm The U.S. Army Medical Research and Development Command (USAMRDC) has selected Empatica to deploy a wearable and algorithm tailored for early and pre-symptomatic detection of COVID-19. The project intended to protect the health of the public by preventing outbreaks via early detection and altering. Empatica’s

A Danish and a Canadian study was conducted, and it has come to the knowledge that the blood type O is very less vulnerable to the coronavirus. Both these studies have been published on Blood Advances. But the researchers have said that a much deeper study is needed in order to come to a definite

Australian scientists have recently reported that the virus which causes novel Coronavirus can last up to 28 days on surfaces such as stainless steel, the glass on the mobile phones, vinyl, and paper banknotes when kept at 20 ºC (68 ºF), which is about room temperature, and in the dark. This indirectly highlights the need

The Institute of Medical Biology which comes under the Chinese Academy of Medical Sciences has developed an experimental coronavirus vaccine that appears to be safe in the human trials.  Negligible Adverse effects : Its researchers said that out of 191 patients of the Phase 1 trial that were given the experimental shots of the vaccination

COVID-19 vaccine has not arrived yet, but the final stage trials may begin from next month along with data publication. COVID-19 vaccine makers Pfizer Inc, Johnson & Johnson, AstraZeneca- Oxford University, and Moderna are eager to conclude final trials. Vaccine manufactures say, “Based on current infection rates, the companies continue to expect that a conclusive

The Russia Direct Investment (RDIF) is currently guiding Russia’s Sputnik V trial vaccine, reaching the Phase 3 trials. RDIF has collaborated with the Hyderabad, India – based Dr.Reddy’s Laboratories to undergo trials, to seek regulatory approval and supply 100 million doses of the COVID-19 vaccine. “We are pleased to partner with RDIF to bring the

The global death rate due to the COVID-19 pandemic is witnessing a rise, hinting towards urgency for the vaccine. ‘The Show cause’ notice Serum Institute received a ‘show cause’ notice from India’s drug regulator after AstraZeneca announced the halt of COVID-19 vaccine trials in the UK amid safety concerns. The Halt of AstraZeneca COVID-19 Vaccine

The company targets 3 billion doses of vaccine, globally As the pandemic continues to spread throughout the world, the need for testing and supplying potential vaccines is on the rise. On August 14th, no profit vaccine access was on the agreement of AstraZeneca concluded with the European Commission supplying up to 400 million doses of